Public records requested under the Freedom of Information Act have helped shape health policy and keep the government ...

Mass layoffs at the Department of Health and Human Services are continuing as the agency makes good on its intention, ...

Rare diseases, often referred to as orphan diseases, affect small patient populations, yet collectively they impact more than ...

The FDA typically files more than 100 complaints a week seeking so-called civil money penalties against retailers, the ...

The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.

The drug, manufactured by the pharmaceutical ... to public input and accountability FOIA is far from a perfect tool for achieving transparency in how the government regulates health and biomedical ...

This article examines the legal implications of AI in healthcare, focusing on liability issues and the need for clear accountability in medical AI applications.

FOIA is far from a perfect tool for achieving transparency in how the government regulates health and biomedical research and policy. In fact, at least at the FDA, FOIA is costly and inefficient ...